ENDoscopic Assessment in Acute PANcreatitis Study (ENDOPAN Study)
Early Upper Gastrointestinal Endoscopic Findings as Predictors of Disease Course and Severity in Acute Pancreatitis: A Prospective Observational Cohort Study
- Acute Pancreatitis (AP)
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Jan Kochanowski University
- Enrolment target
- 200
- Started
- 1 September 2026
- Main results due
- 28 February 2029
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Age 18 years or older. * Diagnosis of acute pancreatitis according to the revised Atlanta criteria, defined by the presence of at least two of the following three features: typical abdominal pain consistent with acute pancreatitis; serum amylase and/or lipase activity at least three times the upper limit of normal; imaging findings consistent with acute pancreatitis. * Hospital admission due to acute pancreatitis to the study center. * Admission during the early phase of acute pancreatitis, allowing planned upper gastrointestinal endoscopy within 24-48 hours from hospital admission. * Ability to undergo diagnostic upper gastrointestinal endoscopy according to the investigator's and treating physician's assessment. * Ability to provide written informed consent before enrollment and before any study-specific procedure. Exclusion Criteria: * Age below 18 years. * Lack of written informed consent. * Inability to provide informed consent before enrollment. * Clinical condition precluding safe diagnostic upper gastrointestinal endoscopy, including hemodynamic instability, severe respiratory failure, or other unstable life-threatening condition. * Need for emergency therapeutic upper gastrointestinal endoscopy before planned study endoscopy, for example due to active upper gastrointestinal bleeding. * Known or suspected gastrointestinal perforation. * Previous gastric or duodenal surgery significantly altering upper gastrointestinal anatomy and preventing reliable assessment of gastric or duodenal mucosa. * Known advanced upper gastrointestinal malignancy affecting the stomach or duodenum. * Pregnancy. * Contraindication to upper gastrointestinal endoscopy or sedation according to the treating physician's or investigator's assessment. * Any condition that, in the investigator's opinion, would make participation unsafe or would prevent completion of study procedures.
What this study is about
In the sponsor’s own words, from the registry.
This is a prospective observational cohort study designed to evaluate early upper gastrointestinal endoscopic findings in adult patients hospitalized with acute pancreatitis. The study aims to determine whether gastric and duodenal mucosal abnormalities detected during early hospitalization are associated with the severity and clinical course of acute pancreatitis.
Adult patients diagnosed with acute pancreatitis according to the revised Atlanta criteria will be enrolled after providing informed consent. Upper gastrointestinal endoscopy will be performed within 24-48 hours from hospital admission. In patients with moderately severe or severe acute pancreatitis, a follow-up endoscopy may be performed before discharge. Clinical, laboratory, imaging, microbiological, and endoscopic data will be collected prospectively during the index hospitalization.
The primary objective is to assess the association between early endoscopic mucosal abnormalities and acute pancreatitis severity according to the revised Atlanta classification. Secondary objectives include evaluation of the relationship between endoscopic findings and organ failure, local or systemic complications, inflammatory markers, nutritional tolerance, length of hospital stay, need for invasive interventions, and in-hospital mortality.
The study has received a positive opinion from the Bioethics Committee of Jan Kochanowski University in Kielce, Collegium Medicum, resolution no. 27/2026 dated May 20, 2026.
Study sites(1)
Department of General, Oncologic and Endocrine Surgery, Regional Hospital in Kielce
Kielce, Poland
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07714850. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me